Cabozantinib S-Malate vs Pembrolizumab

## Cabozantinib S-Malate vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Cabozantinib S-Malate** and **Pembrolizumab**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Cabozantinib S-Malate — N/A; Pembrolizumab — 26 days.

## Chemical Properties

**Type**: Cabozantinib S-Malate — Small molecule; Pembrolizumab — Antibody.